Evidence map›Paper›PMID 38759470›Full record

ReviewNeuroscience and biobehavioral reviews2024

Implication of regional selectivity of dopamine deficits in impaired suppressing of involuntary movements in Parkinson's disease.

Hyunchan Lee, Hyoung F Kim, Okihide Hikosaka

Abstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Parkinson's disease · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hyunchan LeeLaboratory of Sensorimotor Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20892-4435, USA. Electronic address: dr.hyunchan@gmail.com.
Hyoung F KimSchool of Biological Sciences, College of Natural Sciences, Seoul National University (SNU), Seoul 08826, Republic of Korea.
Okihide HikosakaLaboratory of Sensorimotor Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20892-4435, USA.

Funding

Neuronal networks for control of eye movementZIAEY000415 · NEI · NATIONAL EYE INSTITUTE · PI HIKOSAKA, OKIHIDE · 2009 to 2025
$35.3M
Intramural NIH HHS ZIA EY000415
6 · The paper itself

Abstract

To improve the initiation and speed of intended action, one of the crucial mechanisms is suppressing unwanted movements that interfere with goal-directed behavior, which is observed relatively aberrant in Parkinson's disease patients. Recent research has highlighted that dopamine deficits in Parkinson's disease predominantly occur in the caudal lateral part of the substantia nigra pars compacta (SNc) in human patients. We previously found two parallel circuits within the basal ganglia, primarily divided into circuits mediated by the rostral medial part and caudal lateral part of the SNc dopamine neurons. We have further discovered that the indirect pathway in caudal basal ganglia circuits, facilitated by the caudal lateral part of the SNc dopamine neurons, plays a critical role in suppressing unnecessary involuntary movements when animals perform voluntary goal-directed actions. We thus explored recent research in humans and non-human primates focusing on the distinct functions and networks of the caudal lateral part of the SNc dopamine neurons to elucidate the mechanisms involved in the impairment of suppressing involuntary movements in Parkinson's disease patients.

Indexed as

DopamineParkinson DiseaseAnimalsDopaminergic NeuronsDyskinesiasHumansNeural PathwaysDopamineDopamine deficiencyMovement disorderProgressive disorderSubcortical brainUncontrolled movements

Identifiers

PMID38759470
PMCPMC11167649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.